Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Jul 4;7(6):e015735.
doi: 10.1136/bmjopen-2016-015735.

Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans

Yan Xie  1 , Benjamin Bowe  1 , Tingting Li  1   2 , Hong Xian  1   3 , Yan Yan  1   4 , Ziyad Al-Aly  1   2   5   6
Affiliations
Observational Study

Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans

Yan Xie et al. BMJ Open. .

Abstract

Objective: Proton pump inhibitors (PPIs) are widely used, and their use is associated with increased risk of adverse events. However, whether PPI use is associated with excess risk of death is unknown. We aimed to examine the association between PPI use and risk of all-cause mortality.

Design: Longitudinal observational cohort study.

Setting: US Department of Veterans Affairs.

Participants: Primary cohort of new users of PPI or histamine H2 receptor antagonists (H2 blockers) (n=349 312); additional cohorts included PPI versus no PPI (n=3 288 092) and PPI versus no PPI and no H2 blockers (n=2 887 030).

Main outcome measures: Risk of death.

Results: Over a median follow-up of 5.71 years (IQR 5.11-6.37), PPI use was associated with increased risk of death compared with H2 blockers use (HR 1.25, CI 1.23 to 1.28). Risk of death associated with PPI use was higher in analyses adjusted for high-dimensional propensity score (HR 1.16, CI 1.13 to 1.18), in two-stage residual inclusion estimation (HR 1.21, CI 1.16 to 1.26) and in 1:1 time-dependent propensity score-matched cohort (HR 1.34, CI 1.29 to 1.39). The risk of death was increased when considering PPI use versus no PPI (HR 1.15, CI 1.14 to 1.15), and PPI use versus no PPI and no H2 blockers (HR 1.23, CI 1.22 to 1.24). Risk of death associated with PPI use was increased among participants without gastrointestinal conditions: PPI versus H2 blockers (HR 1.24, CI 1.21 to 1.27), PPI use versus no PPI (HR 1.19, CI 1.18 to 1.20) and PPI use versus no PPI and no H2 blockers (HR 1.22, CI 1.21 to 1.23). Among new PPI users, there was a graded association between the duration of exposure and the risk of death.

Conclusions: The results suggest excess risk of death among PPI users; risk is also increased among those without gastrointestinal conditions and with prolonged duration of use. Limiting PPI use and duration to instances where it is medically indicated may be warranted.

Keywords: Adverse events; CLINICAL PHARMACOLOGY; EPIDEMIOLOGY; Gastroduodenal disease; Health & safety; PUBLIC HEALTH.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Survival curves for PPI and H2 blockers. PPI, proton pump inhibitor.
Figure 2
Figure 2
Duration of PPI exposure and risk of death among new PPI users (n=166 098). PPI, proton pump inhibitor.
See this image and copyright information in PMC

Comment in

References

    1. Schoenfeld AJ, Grady D. Adverse effects associated with proton pump inhibitors. JAMA Intern Med 2016;176:172–4. 10.1001/jamainternmed.2015.7927 - DOI - PubMed
    1. Xie Y, Bowe B, Li T, et al. . Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 2016;27:3153–63. 10.1681/ASN.2015121377 - DOI - PMC - PubMed
    1. Antoniou T, Macdonald EM, Hollands S, et al. . Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study. CMAJ Open 2015;3:E166–E171. 10.9778/cmajo.20140074 - DOI - PMC - PubMed
    1. Klepser DG, Collier DS, Cochran GL. Proton pump inhibitors and acute kidney injury: a nested case-control study. BMC Nephrol 2013;14:150 10.1186/1471-2369-14-150 - DOI - PMC - PubMed
    1. Blank ML, Parkin L, Paul C, et al. . A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. Kidney Int 2014;86:837–44. 10.1038/ki.2014.74 - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources